Physician profile
Brian G Cuddy
NPI 1629037924
$8,587.24
in general payments reported to CMS, 2019-2025
12 companies · $29.18 in 2025
The $29.18 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,896 · 2020: $1,957 · 2021: $134 · 2022: $35.39 · 2023: $287 · 2024: $248 · 2025: $29.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Elements, INC. | $4,339.41 | 2019-2020 | |
| Medtronic USA, INC. | $3,265.01 | 2019-2020 | |
| Stryker Corporation | $280.59 | 2023-2025 | Spinejack, Mako, Prolift |
| Abbott Laboratories | $195.46 | 2020-2024 | Eterna, Proclaim |
| Medtronic, INC. | $168.35 | 2021-2025 | Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Boston Scientific Corporation | $100.23 | 2019-2024 | |
| Providence Medical Technology, INC. | $86.74 | 2024 | |
| Surgalign Spine Technologies, INC. | $49.43 | 2019-2020 | |
| Kuros Biosciences USA, INC | $48.61 | 2023 | |
| Intrinsic Therapeutics | $30.24 | 2021 | |
| Integra Lifesciences Corporation | $11.73 | 2019 | |
| Si-Bone, INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cuddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.